Literature DB >> 3431599

Circadian rhythm of the Bmax of [3H]-imipramine binding in rabbit platelets.

A M Galzin1, S Z Langer.   

Abstract

[3H]-imipramine binding was measured in rabbit blood platelet membranes on a 24 h cycle. Animals were kept on a 14 h light (L) 10 h dark (D) schedule, and blood samples were collected at L + 2, L + 8, D + 2, D + 8 and L + 2 h on a following cycle. Significant differences were found for Bmax values of [3H]-imipramine binding, with highest values during the dark phase and lowest during the light phase. No significant differences were found in Kd values. These results suggest the existence of a circadian rhythm for the Bmax of [3H]-imipramine binding in blood platelets.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3431599     DOI: 10.1007/BF00164884

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  19 in total

1.  Temporal distribution of [3H]-imipramine binding in rat brain regions is not changed by chronic methamphetamine.

Authors:  K Kraeuchi; A Wirz-Justice; T Morimasa; R Suetterlin-Willener; H Feer
Journal:  Chronobiol Int       Date:  1986       Impact factor: 2.877

2.  Modification of ligand binding to membranes by a soluble acceptor. Alpha-1-acid glycoprotein attenuates 3H-imipramine binding to cerebral membranes.

Authors:  A I Barkai; M Baron; S Kowalik; T B Cooper
Journal:  Biol Psychiatry       Date:  1986-08       Impact factor: 13.382

3.  Circadian rhythm of serotonin transport in human platelets.

Authors:  I Modai; R Malmgren; M Asberg; H Beving
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

5.  Pitfalls in demonstrating an endogenous ligand of imipramine recognition sites.

Authors:  C R Lee; A M Galzin; M A Taranger; S Z Langer
Journal:  Biochem Pharmacol       Date:  1987-03-15       Impact factor: 5.858

6.  Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.

Authors:  S Z Langer; A M Galzin; M F Poirier; H Loo; D Sechter; E Zarifian
Journal:  J Recept Res       Date:  1987

7.  Long-term effect of lithium on the uptake of 5-hydroxytryptamine by human platelets.

Authors:  G V Born; G Grignani; K Martin
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

8.  Antidepressant-binding sites in brain and platelets.

Authors:  S Z Langer; A M Galzin; C R Lee; H Schoemaker
Journal:  Ciba Found Symp       Date:  1986

9.  Allosteric interaction between the site labeled by [3H]imipramine and the serotonin transporter in human platelets.

Authors:  L R Meyerson; J R Ieni; L P Wennogle
Journal:  J Neurochem       Date:  1987-02       Impact factor: 5.372

10.  Inhibition of 3H-imipramine binding by plasma from depressed and normal subjects.

Authors:  A I Barkai; M Baron; S Kowalik; T B Cooper
Journal:  Psychiatry Res       Date:  1986-04       Impact factor: 3.222

View more
  2 in total

Review 1.  Studies on the serotonin transporter in platelets.

Authors:  S Z Langer; A M Galzin
Journal:  Experientia       Date:  1988-02-15

2.  Light-dark differences in [3H]-paroxetine binding to rabbit platelet membranes.

Authors:  P Rocca; A M Galzin; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.